Glycosphingolipid antigens and cancer therapy
- 31 December 1997
- journal article
- review article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 4 (2), 97-104
- https://doi.org/10.1016/s1074-5521(97)90253-2
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Total Synthesis of Sialylgalactosylgloboside: Stage-Specific Embryonic Antigen 4The Journal of Organic Chemistry, 1996
- Total Synthesis of a Human Breast Tumor Associated AntigenJournal of the American Chemical Society, 1995
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- A facile total synthesis of ganglioside GD2Carbohydrate Research, 1994
- Tumor Antigens Known to be Immunogenic in ManAnnals of the New York Academy of Sciences, 1993
- Selectin GMP-140 (CD62; PADGEM) binds to sialosyl-Lea and sialosyl-Lex, and sulfated glycans modulate this bindingBiochemical and Biophysical Research Communications, 1991
- Synergistic effect of two cell recognition systems: glycosphingolipid-glycosphingolipid interaction and integrin receptor interaction with pericellular matrix proteinGlycobiology, 1991
- Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis ABiochemical and Biophysical Research Communications, 1991
- A practical and enantioselective synthesis of glycosphingolipids and related compounds. Total synthesis of globotriaosylceramide (Gb3)Journal of the American Chemical Society, 1988
- Synthesis of a hematoside (GM3-ganglioside) and a stereoisomerGlycoconjugate Journal, 1985